Neogen Chemicals to acquire 100% stake in BuLi Chemicals India from Livent
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
Subscribe To Our Newsletter & Stay Updated